透析患者潜伏性结核治疗结局:回顾性队列研究
该回顾性队列研究纳入加拿大不列颠哥伦比亚省2001至2017年起始透析并接受潜伏性结核感染(LTBI)治疗的365人,其中近期队列290人、历史队列75人。结果显示81.6%成功完成治疗,21.1%发生3-4级不良事件或任何级别皮疹,无治疗相关死亡,近期与历史队列结局无显著差异。
要点
- 维持性透析患者LTBI治疗完成率高,但3-4级不良事件发生率也较高。
- 不良事件多与胃肠道反应、乏力或瘙痒相关,常需调整方案。
- 系统性筛查项目开展前后,治疗结局无显著差异。
核心结论
- 维持性透析患者接受LTBI治疗完成比例高,但3-4级不良事件发生率较高且常需换药。
- LTBI治疗可能安全,但需要密切监测。
研究设计与样本
- 回顾性队列研究,纳入加拿大不列颠哥伦比亚省2001年1月1日至2017年5月31日起始透析至少90天并开始LTBI治疗的365人。
- 近期队列为2012年1月1日及以后开始LTBI治疗者290人(79.5%),历史队列为2012年1月1日前开始者75人(20.5%)。
主要发现
- 298人(81.6%)成功完成LTBI治疗。
- 21.1%的人发生3-4级不良事件或任何级别皮疹,多数不良事件与胃肠道事件、全身乏力或瘙痒相关并导致方案改变。
- 2人(0.5%)因LTBI治疗相关不良事件住院,无5级不良事件(死亡)归因于LTBI治疗。
- 近期与历史队列在所有关注结局上均无显著差异。
临床怎么用
- 对维持性透析患者可考虑LTBI治疗,但应密切监测不良事件并及时调整方案。
局限性
- 回顾性数据,且结果在低结核负担地区以外的推广性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVES: Maintenance dialysis patients are at an increased risk for active tuberculosis (TB). In 2012, British Columbia, Canada, began systematically screening maintenance dialysis patients for latent TB infection (LTBI) and treating people with evidence of LTBI when appropriate. We examined LTBI treatment outcomes and compared treatment outcomes before and after rollout of the systematic screening program. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: The study comprised 365 people in British Columbia, Canada, initiating at least 90 days of dialysis from January 1, 2001, to May 31, 2017, and starting LTBI therapy: 290 (79.5%) people in the recent cohort and 75 (20.5%) in the historical cohort. People starting LTBI therapy from January 1, 2012, onward were classified as the recent cohort, whereas people starting LTBI therapy before January 1, 2012, were classified as the historical cohort. EXPOSURE: Systematic LTBI screening and therapy. OUTCOMES: Proportion of people who experience grade 3 to 5 adverse events (AEs) or any grade rash and end-of-treatment outcomes. ANALYTICAL APPROACH: Outcomes were reported using descriptive statistics. 2-sample test of proportions using χ2 distribution was used to test for statistical significance between the recent and historical cohorts. RESULTS: 298 (81.6%) people successfully completed LTBI therapy. The proportion of people experiencing a grade 3 to 4 AE or any grade rash was 21.1%. Most AEs were related to gastrointestinal events, general malaise, or pruritus that resulted in regimen changes. 2 (0.5%) people were hospitalized for AEs related to LTBI therapy. No significant difference was found between the recent and historical cohorts in all outcomes of interest. No grade 5 AEs (deaths) were attributed to LTBI therapy. LIMITATIONS: Retrospective data and generalizability outside low-TB-burden settings. CONCLUSIONS: Our findings suggest that a high proportion of people receiving maintenance dialysis can complete LTBI therapy. The rate of grade 3 to 4 AEs was high and associated with frequent medication changes during therapy. LTBI therapy in maintenance dialysis may be safe but requires close monitoring.
引用
- Chiang LY, Baumann B, Romanowski K, et al. Latent Tuberculosis Therapy Outcomes in Dialysis Patients: A Retrospective Cohort. Am J Kidney Dis. 2020. PMID: 32818551. doi:10.1053/j.ajkd.2020.06.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。